Liebel-flarsheim Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LIEBEL-FLARSHEIM, and what generic and branded alternatives to LIEBEL-FLARSHEIM drugs are available?
LIEBEL-FLARSHEIM has eleven approved drugs.
Drugs and US Patents for Liebel-flarsheim
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liebel-flarsheim | CONRAY 43 | iothalamate meglumine | INJECTABLE;INJECTION | 013295-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Liebel-flarsheim | OPTIRAY 350 | ioversol | INJECTABLE;INJECTION | 019710-005 | Jan 22, 1992 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Liebel-flarsheim | CYSTO-CONRAY II | iothalamate meglumine | SOLUTION;INTRAVESICAL | 017057-002 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Liebel-flarsheim
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Liebel-flarsheim | OPTIRAY 160 | ioversol | INJECTABLE;INJECTION | 019710-003 | Dec 30, 1988 | 4,396,598 | ⤷ Try a Trial |
Liebel-flarsheim | OPTIMARK | gadoversetamide | INJECTABLE;INJECTION | 020937-002 | Dec 8, 1999 | 5,130,120 | ⤷ Try a Trial |
Liebel-flarsheim | OPTIRAY 240 | ioversol | INJECTABLE;INJECTION | 020923-001 | May 28, 1998 | 4,396,598 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.